Correlations were observed between the Brixia score, symptom duration from onset, and CRP levels, with the sensitivity of radiological lesions as a marker of COVID-19 progression estimated at 61.1% and 68.1% [28,29]. The gene discussed is CRP; the disease is COVID-19.